BG105688A - Utilization of compounds for the prophylaxis and therapy of cerbral ischaemia - Google Patents

Utilization of compounds for the prophylaxis and therapy of cerbral ischaemia

Info

Publication number
BG105688A
BG105688A BG105688A BG10568801A BG105688A BG 105688 A BG105688 A BG 105688A BG 105688 A BG105688 A BG 105688A BG 10568801 A BG10568801 A BG 10568801A BG 105688 A BG105688 A BG 105688A
Authority
BG
Bulgaria
Prior art keywords
prophylaxis
therapy
utilization
compounds
ischaemia
Prior art date
Application number
BG105688A
Other languages
Bulgarian (bg)
English (en)
Inventor
Gerd Steiner
Kurt SCHNELLHAAS
Wilfried Lubisch
Uta Holzenkamp
Dorothea Starck
Laszlo Szabo
Franz Emling
Francisco Garcia-Ladona
Hans-Peter Hofmann
Liliane Unger
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of BG105688A publication Critical patent/BG105688A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG105688A 1999-01-11 2001-07-10 Utilization of compounds for the prophylaxis and therapy of cerbral ischaemia BG105688A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19900544A DE19900544A1 (de) 1999-01-11 1999-01-11 Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie
PCT/EP1999/010275 WO2000041697A1 (de) 1999-01-11 1999-12-22 Verwendung von 2-substituierten 1,2-benzisothiazol-derivaten und von 3-substituierten tetrahydropyridopyrimidinon-derivaten zur prophylaxe und therapie der zerebralen ischämie

Publications (1)

Publication Number Publication Date
BG105688A true BG105688A (en) 2002-02-28

Family

ID=7893835

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105688A BG105688A (en) 1999-01-11 2001-07-10 Utilization of compounds for the prophylaxis and therapy of cerbral ischaemia

Country Status (19)

Country Link
EP (1) EP1140099A1 (xx)
JP (1) JP2002534467A (xx)
KR (1) KR20010101440A (xx)
CN (1) CN1333685A (xx)
AR (1) AR029741A1 (xx)
AU (1) AU2285100A (xx)
BG (1) BG105688A (xx)
BR (1) BR9916888A (xx)
CA (1) CA2359390A1 (xx)
DE (1) DE19900544A1 (xx)
HU (1) HUP0200520A3 (xx)
IL (1) IL144145A0 (xx)
MX (1) MXPA01006966A (xx)
NO (1) NO20013408L (xx)
PL (1) PL348916A1 (xx)
SK (1) SK9682001A3 (xx)
TR (1) TR200102009T2 (xx)
WO (1) WO2000041697A1 (xx)
ZA (1) ZA200105473B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4654035B2 (ja) 2002-11-05 2011-03-16 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 抗菌剤
CA2539479C (en) * 2003-09-23 2010-07-06 Merck & Co., Inc. Isoquinoline potassium channel inhibitors
CN101296914B (zh) * 2005-08-26 2012-07-18 盐野义制药株式会社 具有ppar激动活性的衍生物
AU2008301884B2 (en) * 2007-09-20 2012-12-20 Cortex Pharmaceuticals, Inc. 3-substituted 1,2,3-triazin-4-one's and 3-substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses
MA41168A (fr) 2014-12-17 2017-10-24 Acraf Nouveaux composés antibactériens
CN108484594B (zh) * 2018-02-09 2020-08-04 福建医科大学 一种烷氧基取代四氢吡啶并嘧啶类化合物或其可用盐及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3620643A1 (de) * 1985-06-22 1987-01-22 Sandoz Ag Thiazole, ihre herstellung und verwendung
DE3831888A1 (de) * 1988-09-20 1990-03-29 Troponwerke Gmbh & Co Kg Arzneimittel zur behandlung von apoplexia cerebri
JP3036789B2 (ja) * 1990-06-22 2000-04-24 三井化学株式会社 新規な複素環式化合物及び医薬組成物
DE19746612A1 (de) * 1997-10-22 1999-04-29 Basf Ag 2-Substituierte 1,2-Benzisothiazol-Derivate, ihre Herstellung und Verwendung
DE19747063A1 (de) * 1997-10-24 1999-04-29 Basf Ag 3-substituierte Tetrahydropyridopyrimidinon-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
CA2359390A1 (en) 2000-07-20
IL144145A0 (en) 2002-05-23
NO20013408D0 (no) 2001-07-10
PL348916A1 (en) 2002-06-17
EP1140099A1 (de) 2001-10-10
DE19900544A1 (de) 2000-07-13
WO2000041697A1 (de) 2000-07-20
ZA200105473B (en) 2002-10-03
HUP0200520A2 (hu) 2002-07-29
MXPA01006966A (es) 2002-04-10
NO20013408L (no) 2001-08-21
BR9916888A (pt) 2001-11-20
CN1333685A (zh) 2002-01-30
KR20010101440A (ko) 2001-11-14
AU2285100A (en) 2000-08-01
SK9682001A3 (en) 2002-03-05
AR029741A1 (es) 2003-07-16
JP2002534467A (ja) 2002-10-15
HUP0200520A3 (en) 2003-04-28
TR200102009T2 (tr) 2002-01-21

Similar Documents

Publication Publication Date Title
BG106585A (en) Kinase inhibitors as therapeutic agents
AP2002002637A0 (en) Novel piperazine
MY128765A (en) Novel benzoimidazole derivatives useful as antiproliferative agents.
PT1416935E (pt) Derivados de 4-amino-6-fenil-pirrolo[2,3-d]pirimidina
CA2478374A1 (en) N3 alkylated benzimidazole derivatives as mek inhibitors
TW200518753A (en) Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
BG106003A (en) New n-cyanomethylamides and compositions as protease inhibitors
BG105515A (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
PL361807A1 (en) Use of substituted imidazo[1,2-a]pyridine-, imidazo[1,2-a]pyrimidine and imidazo[1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments
MY134222A (en) NEW MEDICAMENT COMPOSITIONS BASED ON ANTICHOLINERGICALLY-EFFECTIVE COMPOUNDS AND ß-MIMETICS
MY115662A (en) Novel compounds with analgesic effect
YU65804A (sh) Nova heterociklična jedinjenja aktivna kao inhibitori beta-laktamaze
GB9914486D0 (en) Medicaments
BG106343A (en) Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
AU3850600A (en) Dalda analogs and their use
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
BG108426A (en) Novel sulfonic acid derivatives
BG105689A (en) Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia
MXPA04006266A (es) Pirimidotriazinas como inhibidores de fosfatasa.
GEP20084376B (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
AP2001002306A0 (en) Bridged piperazine derivatives.
SE0203070D0 (en) Novel compounds
MY133785A (en) Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
BG105688A (en) Utilization of compounds for the prophylaxis and therapy of cerbral ischaemia